What Growth Hormone Does in the Body and How Certain Peptides May Increase GH Signaling
Growth hormone, often shortened to GH, is a hormone released by the pituitary gland. It is best known for its role in childhood growth, but it also matters in adults. In adults, GH helps regulate body composition, fat metabolism, bone remodeling, recovery biology, and the insulin-like growth factor 1 pathway, also called IGF-1. GH does not work alone. Many of its effects are connected to IGF-1, which is produced mainly in the liver after GH signaling. (NCBI)
The peptide conversation around growth hormone usually focuses on compounds that may stimulate the body’s own GH release rather than directly injecting recombinant human growth hormone. These are often called growth hormone secretagogues or growth hormone-releasing hormone analogs. Common examples include ipamorelin, CJC-1295, tesamorelin, sermorelin, GHRP-2, GHRP-6, and hexarelin. Some non-peptide compounds, like MK-677 / ibutamoren, are also discussed in this category because they may stimulate GH release, even though they are not technically peptides.
What Does Growth Hormone Do?
Growth hormone helps regulate several systems in the body. It affects fat metabolism, carbohydrate metabolism, protein turnover, bone remodeling, and body composition. Reviews of GH physiology show that GH strongly stimulates lipolysis, meaning the breakdown of stored fat, and increases circulating free fatty acids. It also interacts with insulin and glucose metabolism, which is why too much GH activity can be associated with insulin resistance in some contexts. (PMC)
GH also affects lean mass and bone. In adults with true growth hormone deficiency, medical GH replacement can improve some deficiency-related changes, including altered body composition, reduced bone remodeling, and increased central adiposity. However, this is different from using GH-related peptides for wellness, bodybuilding, anti-aging, or performance enhancement in people who do not have diagnosed GH deficiency. Endocrine Society guidance emphasizes formal testing for suspected adult GH deficiency and treatment only in proven cases when there are no contraindications. (Endocrine Society)
The GH and IGF-1 Pathway
A simple way to understand the pathway is this:
The hypothalamus releases signals that regulate the pituitary gland.
The pituitary gland releases growth hormone in pulses.
Growth hormone travels through the bloodstream.
The liver and other tissues respond by producing IGF-1.
IGF-1 helps mediate many growth-related and anabolic effects.
This is why many GH-related peptides are discussed as “pulse amplifiers.” They are not all the same, but the general idea is that they may signal the pituitary to release more GH or support the GH pulse pattern.
How Peptides May Increase Growth Hormone
Peptides that may increase GH generally work through one of two pathways.
The first pathway is the growth hormone-releasing hormone pathway, also called the GHRH pathway. Peptides like sermorelin, CJC-1295, and tesamorelin are related to this pathway. They mimic or modify growth hormone-releasing hormone, which tells the pituitary gland to release GH.
The second pathway is the growth hormone secretagogue receptor pathway, sometimes linked to the ghrelin receptor. Peptides like ipamorelin, GHRP-2, GHRP-6, and hexarelin are usually discussed in this category. These compounds may stimulate GH release through secretagogue signaling. Scientific reviews describe growth hormone secretagogues as compounds that can stimulate GH release, with some acting through the ghrelin receptor. (PubMed)
Ipamorelin
Ipamorelin is a synthetic growth hormone secretagogue. It is often marketed in wellness and fitness settings for GH support, recovery, sleep, body composition, and anti-aging. Mechanistically, it is usually discussed as a ghrelin receptor-related secretagogue that may stimulate GH release.
One reason ipamorelin gets attention is that early research described it as more selective than older GHRPs. A study comparing ipamorelin with GHRP-2 and GHRP-6 reported that GHRP-2 and GHRP-6 increased ACTH and cortisol, while ipamorelin did not show the same ACTH/cortisol release pattern in that study. (PubMed)
That does not mean ipamorelin is proven for bodybuilding, anti-aging, or general wellness use. It means it has been studied as a GH secretagogue. It is not an FDA-approved peptide drug for increasing GH in healthy adults.
CJC-1295
CJC-1295 is a long-acting analog of growth hormone-releasing hormone. It was designed to extend GHRH activity and stimulate GH and IGF-1 over a longer period than natural GHRH. In a randomized, placebo-controlled study, CJC-1295 increased GH and IGF-1 levels after administration and had a prolonged pharmacologic effect. (PubMed)
In wellness settings, CJC-1295 is often paired with ipamorelin. The idea is that CJC-1295 supports the GHRH side of GH release, while ipamorelin supports the secretagogue side. This “two-pathway” concept is popular, but clinical use for general body composition, anti-aging, or gym recovery remains a different question from whether the compounds can alter GH markers.
Tesamorelin
Tesamorelin is one of the most important compounds in this category because it has a legitimate prescription-drug context. It is a synthetic growth hormone-releasing hormone analog. Mayo Clinic describes tesamorelin as similar to a hormone normally released from the hypothalamus and used to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. (Mayo Clinic)
Cleveland Clinic also explains that tesamorelin works by increasing growth hormone levels in the body and is used for excess stomach-area fat in people with HIV and lipodystrophy. (Cleveland Clinic)
That distinction matters. Tesamorelin is not simply a generic “fat-loss peptide.” Its approved medical context is specific. Using the tesamorelin mechanism to talk about GH signaling is fair, but it should not be presented as a general-purpose bodybuilding or weight-loss claim.
Sermorelin
Sermorelin is a synthetic analog of growth hormone-releasing hormone. It is designed to stimulate the pituitary gland to release GH. Sermorelin is commonly discussed in age-management and wellness clinics as a way to support GH signaling, but it is not the same as directly replacing GH.
The important distinction is that sermorelin depends on pituitary responsiveness. If the pituitary cannot respond properly, stimulating it may not create the desired GH release. In mainstream endocrine care, adult GH deficiency is diagnosed through formal stimulation testing, and guidelines focus on GH replacement for proven GH deficiency rather than broad use of GH secretagogues for wellness. (Endocrine Society)
GHRP-2 and GHRP-6
GHRP-2 and GHRP-6 are older synthetic growth hormone-releasing peptides. They are part of the classic GH secretagogue discussion. Scientific reviews describe synthetic GHRPs, including GHRP-2 and GHRP-6, as compounds studied for their ability to stimulate GH release. (PMC)
In fitness circles, GHRP-6 is often associated with appetite stimulation, while GHRP-2 is often discussed as somewhat stronger or more direct. However, these are not FDA-approved wellness peptides, and their broader safety profile, product quality, and real-world use risks remain concerns.
Hexarelin
Hexarelin is another synthetic GH secretagogue. It is typically considered more potent in GH-release discussions than some other GHRPs, but it may also be associated with more concern around effects on other hormones such as cortisol or prolactin, depending on context and study design.
For content purposes, hexarelin belongs in the “claims to increase GH” category, but it should be framed as experimental or research-based rather than as a proven wellness tool.
MK-677 / Ibutamoren
MK-677, also called ibutamoren, is often discussed alongside GH peptides, but it is important to be precise: MK-677 is not technically a peptide. It is an oral growth hormone secretagogue that acts through the ghrelin receptor pathway. It is popular in bodybuilding and biohacking discussions because it is oral and may increase GH and IGF-1 markers.
Because it is not a peptide, it should not be listed as a therapeutic peptide. But if the topic is “compounds that claim to increase GH production,” MK-677 belongs in the broader conversation.
Other Compounds Often Mentioned in GH Conversations
Other GH-related or GH-adjacent compounds include:
GHRH, the natural hypothalamic hormone that signals the pituitary to release GH.
GHK-Cu, sometimes discussed in tissue and skin repair, but it is not primarily a GH-increasing peptide.
AOD-9604, a fragment related to growth hormone research, but it is usually discussed for fat metabolism and is not the same as increasing GH production.
IGF-1 LR3, which is not a GH secretagogue. It is an IGF-1 analog, meaning it is downstream of GH signaling rather than a peptide that stimulates GH production.
These distinctions matter because the peptide market often lumps everything together. A GH secretagogue, a GHRH analog, an IGF-1 analog, and a GH fragment are not the same thing.
Why People Care About GH Peptides
The fitness and wellness interest usually centers around body composition, recovery, sleep quality, skin appearance, fat metabolism, and aging. GH has real effects on fat metabolism and body composition, and GH deficiency can be associated with increased central adiposity and other changes. (NCBI)
But it is not accurate to jump from “GH affects body composition” to “GH peptides safely build muscle or burn fat in healthy adults.” The clinical evidence, regulatory status, dose, route, patient selection, and safety monitoring all matter.
Safety Considerations
Increasing GH signaling is not automatically harmless. GH interacts with glucose and insulin biology, and reviews note that GH can promote insulin resistance through effects on lipolysis and free fatty acid levels. (PMC)
Potential concerns with GH-related stimulation may include water retention, joint discomfort, numbness or tingling, changes in glucose control, increased IGF-1, appetite changes, and unknown long-term risks depending on the compound. Product quality is also a major issue when peptides are purchased outside regulated medical supply chains.
This is why credible content should avoid saying these peptides “boost GH safely” or “increase muscle.” A more accurate phrase is: these compounds are discussed or studied for their ability to stimulate GH release or GH-related pathways, but safety, approval status, and human evidence vary widely.
Simple Comparison Table
| Compound | Category | How it may affect GH | Regulatory/evidence note |
|---|---|---|---|
| Tesamorelin | GHRH analog | Stimulates endogenous GH secretion | Prescription context for HIV-associated lipodystrophy |
| Sermorelin | GHRH analog | Signals pituitary to release GH | Used in wellness settings, but not a general FDA-approved anti-aging peptide |
| CJC-1295 | Long-acting GHRH analog | Can increase GH and IGF-1 markers | Studied in humans, not broadly FDA-approved for wellness use |
| Ipamorelin | GH secretagogue | Stimulates GH release through secretagogue pathways | Research/wellness compound, not FDA-approved for general GH boosting |
| GHRP-2 | GH-releasing peptide | Stimulates GH release | Research compound with broader hormone concerns |
| GHRP-6 | GH-releasing peptide | Stimulates GH release and may affect appetite | Research compound, not approved for general wellness use |
| Hexarelin | GH secretagogue | Potent GH-release stimulation in research settings | Experimental/research context |
| MK-677 / Ibutamoren | Non-peptide GH secretagogue | Oral ghrelin-receptor agonist that may increase GH/IGF-1 | Not technically a peptide |
A Quick Summary
Growth hormone is involved in growth, fat metabolism, body composition, bone remodeling, and IGF-1 signaling. Peptides like tesamorelin, sermorelin, CJC-1295, ipamorelin, GHRP-2, GHRP-6, and hexarelin are discussed because they may stimulate the body’s own GH-release pathways.
The most credible distinction is this: these compounds may influence GH signaling, but they are not all approved, equivalent, or proven for the same uses. Tesamorelin has a specific prescription-drug role. CJC-1295 has human research showing GH and IGF-1 increases. Sermorelin, ipamorelin, GHRPs, and hexarelin are commonly discussed in wellness and fitness spaces, but their use for anti-aging, bodybuilding, or general recovery is not the same as FDA-approved medical treatment.
The smart way to talk about GH peptides is not “they boost growth hormone and build muscle.” The better answer is: they may stimulate GH-related pathways, but the real-world outcome depends on the compound, evidence level, dose, medical status, and safety oversight.